Savara Inc. (SVRA) is a publicly traded Healthcare sector company. As of May 21, 2026, SVRA trades at $4.95 with a market cap of $1.01B and a P/E ratio of -9.48. SVRA moved +7.84% today. Year to date, SVRA is -12.41%; over the trailing twelve months it is +62.04%. Its 52-week range spans $1.89 to $7.01. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces SVRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SVRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SVRA recently traded at $4.95. Market cap is $1.01B. P/E ratio is -9.48. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $4.95 |
| Market Cap | $1.01B |
| P/E Ratio | -9.48 |
| EPS | $-0.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.01 |
| 52-Week Low | $1.89 |
| Volume | 476 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-118.84M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-118.84M | $-0.53 |
| 2024 | $0 | $-95.88M | $-0.48 |
| 2023 | $0 | $-54.70M | $-0.33 |
| 2022 | $0 | $-38.15M | $-0.25 |
6 analysts cover SVRA: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.00.